Announcement, Partner Highlight, Press Release | 04.24.25 Immunai and the Parker Institute Collaborate to Build One of the Largest Single-Cell Datasets in Cancer
Announcement, Press Release | 04.10.25 Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
Announcement, Press Release | 03.31.25 Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
Announcement, Press Release | 11.19.24 Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release | 10.03.24 PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release | 07.31.24 Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release | 07.18.24 Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release | 06.27.24 The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators
Press Release | 04.30.24 BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Announcement, Press Release | 12.13.23 Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium
Announcement, Our Impact, Press Release | 06.27.23 Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Announcement, Partner Highlight, Press Release | 08.24.22 LumaBridge and the Parker Institute for Cancer Immunotherapy Form Strategic Alliance to Speed Access to Clinical Trial Services for Partners